Perrigo Initiates Voluntary Product Recall in the U.S.

Posted: Jan. 13, 2016

Perrigo Initiates Voluntary Product Recall in the U.S. Of Children's Guaifenesin Grape Liquid and Guaifenesin DM Cherry Liquid Due to a Potential Defect with the Dosage Cup

From drugs.com (edited)


Perrigo Company plc (NYSE: PRGO; TASE) of Dublin, Ireland, announced on January 11th that, following the recent recall of certain dosing cups by its supplier, it has initiated a voluntary product recall in the US  to the retail level of 2 batches of its children's guaifenesin grape liquid (100mg/5 mL) and 3 batches of its children's guaifenesin DM cherry liquid (100mg guaifenesin and 5mg dextromethorphan HBr/ 5 ml) sold in 4 oz. bottles with dosage cup in a box under the store brand products listed below. This recall is being initiated because some packages contain an oral dosing cup with incorrect dose markings.

GUAIFENESIN GRAPE LIQ 4 OZ

Label

 Lot number

Expiry

H.E.B

5LK0592

08/2017

CVS

5MK0340

08/2017

GUAIFENESIN DM CHRY LIQ 4 OZ

Label

Lot number

Expiry

Sunmark

5LK0528, 5LK0630

03/2017

Rite-Aid

5LK0528, 5LK0630

03/2017

Topcare

5LK0528, 5LK0630, 5LK0779

03/2017

Kroger

5LK0528, 5LK0630

03/2017

GoodSense

5LK0528

03/2017

Dollar General

5LK0630

03/2017

Care One

5LK0630

03/2017

CVS

5LK0630

03/2017